Detalhe da pesquisa
1.
HIV pre-exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID).
HIV Med
; 25(3): 353-360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040445
2.
The Mersey Burns App: evolving a model of validation.
Emerg Med J
; 32(8): 637-41, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371408
3.
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial.
Lancet HIV
; 11(3): e156-e166, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417976
4.
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19.
Infect Dis Now
; 53(7): 104760, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37454762